219 related articles for article (PubMed ID: 23204230)
1. Targeting galectin-1 overcomes breast cancer-associated immunosuppression and prevents metastatic disease.
Dalotto-Moreno T; Croci DO; Cerliani JP; Martinez-Allo VC; Dergan-Dylon S; Méndez-Huergo SP; Stupirski JC; Mazal D; Osinaga E; Toscano MA; Sundblad V; Rabinovich GA; Salatino M
Cancer Res; 2013 Feb; 73(3):1107-17. PubMed ID: 23204230
[TBL] [Abstract][Full Text] [Related]
2. Osteopontin shapes immunosuppression in the metastatic niche.
Sangaletti S; Tripodo C; Sandri S; Torselli I; Vitali C; Ratti C; Botti L; Burocchi A; Porcasi R; Tomirotti A; Colombo MP; Chiodoni C
Cancer Res; 2014 Sep; 74(17):4706-19. PubMed ID: 25035397
[TBL] [Abstract][Full Text] [Related]
3. The absence of B lymphocytes reduces the number and function of T-regulatory cells and enhances the anti-tumor response in a murine tumor model.
Tadmor T; Zhang Y; Cho HM; Podack ER; Rosenblatt JD
Cancer Immunol Immunother; 2011 May; 60(5):609-19. PubMed ID: 21253724
[TBL] [Abstract][Full Text] [Related]
4. Galectin-1 confers immune privilege to human trophoblast: implications in recurrent fetal loss.
Ramhorst RE; Giribaldi L; Fraccaroli L; Toscano MA; Stupirski JC; Romero MD; Durand ES; Rubinstein N; Blaschitz A; Sedlmayr P; Genti-Raimondi S; Fainboim L; Rabinovich GA
Glycobiology; 2012 Oct; 22(10):1374-86. PubMed ID: 22752006
[TBL] [Abstract][Full Text] [Related]
5. Combined IFN-gamma-endostatin gene therapy and radiotherapy attenuates primary breast tumor growth and lung metastases via enhanced CTL and NK cell activation and attenuated tumor angiogenesis in a murine model.
Liu LL; Smith MJ; Sun BS; Wang GJ; Redmond HP; Wang JH
Ann Surg Oncol; 2009 May; 16(5):1403-11. PubMed ID: 19263173
[TBL] [Abstract][Full Text] [Related]
6. Silencing of TLR4 increases tumor progression and lung metastasis in a murine model of breast cancer.
Ahmed A; Wang JH; Redmond HP
Ann Surg Oncol; 2013 Dec; 20 Suppl 3():S389-96. PubMed ID: 22890596
[TBL] [Abstract][Full Text] [Related]
7. Galectin-1 as a potent target for cancer therapy: role in the tumor microenvironment.
Ito K; Stannard K; Gabutero E; Clark AM; Neo SY; Onturk S; Blanchard H; Ralph SJ
Cancer Metastasis Rev; 2012 Dec; 31(3-4):763-78. PubMed ID: 22706847
[TBL] [Abstract][Full Text] [Related]
8. Depletion of CD4+CD25+ regulatory T cells promotes a tumor-specific immune response in pancreas cancer-bearing mice.
Viehl CT; Moore TT; Liyanage UK; Frey DM; Ehlers JP; Eberlein TJ; Goedegebuure PS; Linehan DC
Ann Surg Oncol; 2006 Sep; 13(9):1252-8. PubMed ID: 16952047
[TBL] [Abstract][Full Text] [Related]
9. Targeting Stat3 induces senescence in tumor cells and elicits prophylactic and therapeutic immune responses against breast cancer growth mediated by NK cells and CD4+ T cells.
Tkach M; Coria L; Rosemblit C; Rivas MA; Proietti CJ; Díaz Flaqué MC; Beguelin W; Frahm I; Charreau EH; Cassataro J; Elizalde PV; Schillaci R
J Immunol; 2012 Aug; 189(3):1162-72. PubMed ID: 22753933
[TBL] [Abstract][Full Text] [Related]
10. Lung cancer-derived galectin-1 mediates dendritic cell anergy through inhibitor of DNA binding 3/IL-10 signaling pathway.
Kuo PL; Hung JY; Huang SK; Chou SH; Cheng DE; Jong YJ; Hung CH; Yang CJ; Tsai YM; Hsu YL; Huang MS
J Immunol; 2011 Feb; 186(3):1521-30. PubMed ID: 21191065
[TBL] [Abstract][Full Text] [Related]
11. Immune compartmentalization of T cell subsets in chemically-induced breast cancer.
Fahmi T; Esendagli G; Yilmaz G; Kansu E; Guc D
Scand J Immunol; 2010 Oct; 72(4):339-48. PubMed ID: 20883319
[TBL] [Abstract][Full Text] [Related]
12. Antagonism of CXCR3 inhibits lung metastasis in a murine model of metastatic breast cancer.
Walser TC; Rifat S; Ma X; Kundu N; Ward C; Goloubeva O; Johnson MG; Medina JC; Collins TL; Fulton AM
Cancer Res; 2006 Aug; 66(15):7701-7. PubMed ID: 16885372
[TBL] [Abstract][Full Text] [Related]
13. Interleukin-12 gene therapy of a weakly immunogenic mouse mammary carcinoma results in reduction of spontaneous lung metastases via a T-cell-independent mechanism.
Rakhmilevich AL; Janssen K; Hao Z; Sondel PM; Yang NS
Cancer Gene Ther; 2000 Jun; 7(6):826-38. PubMed ID: 10880012
[TBL] [Abstract][Full Text] [Related]
14. Expression of tumor necrosis factor-α induced protein 8 like-2 contributes to the immunosuppressive property of CD4(+)CD25(+) regulatory T cells in mice.
Luan YY; Yao YM; Zhang L; Dong N; Zhang QH; Yu Y; Sheng ZY
Mol Immunol; 2011 Oct; 49(1-2):219-26. PubMed ID: 21963221
[TBL] [Abstract][Full Text] [Related]
15. In situ expression of IFN-gamma-inducible T cell alpha chemoattractant in breast cancer mounts an enhanced specific anti-tumor immunity which leads to tumor regression.
Chu Y; Yang X; Xu W; Wang Y; Guo Q; Xiong S
Cancer Immunol Immunother; 2007 Oct; 56(10):1539-49. PubMed ID: 17659370
[TBL] [Abstract][Full Text] [Related]
16. Intrinsic focal adhesion kinase activity controls orthotopic breast carcinoma metastasis via the regulation of urokinase plasminogen activator expression in a syngeneic tumor model.
Mitra SK; Lim ST; Chi A; Schlaepfer DD
Oncogene; 2006 Jul; 25(32):4429-40. PubMed ID: 16547501
[TBL] [Abstract][Full Text] [Related]
17. Combined therapy of local and metastatic 4T1 breast tumor in mice using SU6668, an inhibitor of angiogenic receptor tyrosine kinases, and the immunostimulator B7.2-IgG fusion protein.
Huang X; Wong MK; Yi H; Watkins S; Laird AD; Wolf SF; Gorelik E
Cancer Res; 2002 Oct; 62(20):5727-35. PubMed ID: 12384531
[TBL] [Abstract][Full Text] [Related]
18. TGF-beta1 modulates Foxp3 expression and regulatory activity in distinct CD4+ T cell subsets.
Pyzik M; Piccirillo CA
J Leukoc Biol; 2007 Aug; 82(2):335-46. PubMed ID: 17475784
[TBL] [Abstract][Full Text] [Related]
19. Surgical injury enhances the expression of genes that mediate breast cancer metastasis to the lung.
Al-Sahaf O; Wang JH; Browne TJ; Cotter TG; Redmond HP
Ann Surg; 2010 Dec; 252(6):1037-43. PubMed ID: 21107114
[TBL] [Abstract][Full Text] [Related]
20. Targeting fibroblast growth factor receptors blocks PI3K/AKT signaling, induces apoptosis, and impairs mammary tumor outgrowth and metastasis.
Dey JH; Bianchi F; Voshol J; Bonenfant D; Oakeley EJ; Hynes NE
Cancer Res; 2010 May; 70(10):4151-62. PubMed ID: 20460524
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
